The influence of prostate volume on prostate cancer detection

European Urology, Supplement

Volumn 1, Issue 6, 2002, Pages 35-39

  Brawer, Michael K ^a  

^a Northwest Prostate Institute   (United States)

Author keywords

Prostate cancer; Prostate volume; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; HUMAN; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

EID: 0036765276     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(02)00055-6     Document Type: Article

References (42)

1. Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK. Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974-1994. J Urol 1997;58(4):1427-30.
2. Lee F, Gray J, McCleary R. Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology and staging. Prostate 1985;7:117-29.
3. Lee F, Littrup PJ, Torp-Pederson ST, Mettlin C, McHugh TA, Gray JM. Prostate cancer: comparison of TRUS and DRE for screening. Radiology 1988;168:389-94.
4. Lee F, Torp-Pedersen ST, McLeary RD. Diagnosis of prostate cancer by transrectal ultrasound. Urol Clin North Am 1989;16:663-73.
5. Lee F, Torp-Pedersen ST, Siders DB, et al. Transrectal ultrasonography in the diagnosis and staging of prostatic carcinoma. Radiology 1989;170:609.
6. Lee FR, Gray JM, McLeary RD, et al. Prostatic evaluation by transrectal sonography: Criteria for diagnosis of early carcinoma. Radiology 1986;158:91-5.
7. Cooner WH, Mosley RB, Rutherford J, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate-specific antigen. J Urol 1990;143:1146-54.
8. Rifkin MD. Endorectal sonography of the prostate: clinical implications. AJR 1987;148:1137-42.
9. Rifkin MD, Friedland GW, Shortliffe L. Prostatic evaluation by transrectal ultrasonography: detection of carcinoma. Radiology 1986; 158:85-90.
10. Watanabe H. Transrectal sonography: a personal review and recent advances. Scand J Urol Nephrol 1991;137:75-83.
11. Resnick MI, et al. Transrectal prostate ultrasonography-variability of interpretation. J Urol 1994;151(Suppl):503A.
12. Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol 1989;142:1008-10.
13. Dahnert WF, Hamper UM, Eggleston JC, Walsh PC, Sanders RC. Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma. Radiology 1986;158:97-102.
14. Salo JO, Rannikko S, Makinen J, Lehtonen T. Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 1987;10:1-9.
15. Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol 1994;152(6):2304-7.
16. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol 1995;153(5):1496-8.
17. Benson MC, Whang IS, Pantuck A, et al. Prostate-specific density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-6.
18. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of PSA density to enhance the predictive value of intermediate levels of serum PSA. J Urol 1992;147:817-21.
19. Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC. PSA density (PSAD): role in patient evaluation and management. Urol Clin North Am 1993;20:653.
20. Bazinet M, Meshref AW, Trudel C, et al. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 1994;43:44-51.
21. Rommel FM, Augusta VE, Breslin JA, et al. The use of PSA and PSAD in the diagnosis of prostate cancer in a community based urology practice. J Urol 1994;151:88-93.
22. Littrup PJ, Kane RA, Mettlin CJ, et al. Cost-effective prostate cancer detection: reduction of low-yield biopsies. Cancer 1994;74(12): 3146-58.
23. Bangma CH, Kranse R, Blijenberg BG, Schroder FH. The value of screening tests in the detection of prostate cancer. Part 1. Results of a retrospective evaluation of 1726 men. Urology 1995;46(6):773-8.
24. Brawer MK, Aramburu EAG, Chen GL, Preston SD, Ellis WJ. The inability of PSA index to enhance the predictive value of PSA in the diagnosis of prostatic carcinoma. J Urol 1993;150:369-73.
25. Mettlin C, Littrup PJ, Kane RA, et al. Relative sensitivity and specificity of serum PSA level compared with age-referenced PSA, PSA density and PSA change. Cancer 1994;74:1615-20.
26. Ohori M, Dunn JK, Scardino PT. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer. Urology 1995;46:666-71.
27. Djavan B, Zlotta AR, Shariat S, Omar M, Schulman CC, Marberger M. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 1998; 160(2):411-8.
28. Maeda H, Ishitoya S, Maekawa S, et al. Prostate specific antigen density of the transition zone in the detection of prostate cancer. J Urol 1997;(Suppl):58A.
29. Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK. Transition zone PSA density: lack of utility in prediction of prostatic carcinoma. J Urol 1998;160:77-82.
30. Letran J, Meyer G, Loberiza F, Brawer M. The effect of prostate volume on the yield of needle biopsy. J Urol 1998;160(5):1718-21.
31. Karakiewicz PL, Bazinet M, Aprikian AG, et al. Outcome of sextant biopsy according to gland volume. Urology 1997; 49(1):55-9.
32. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byme JC, Vaughan ED. The influence of prostatic size on cancer detection. Urology 1995;46:821.
33. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate-specific antigen levels. J Urol 1994;151:1571-4.
34. Roehrborn CG, Pickens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels. Urology 1996;47:347-52.
35. Hodge KK, McNeal SE, Terris MK, Stamey TA. Random systematic versus directed ultrasound-guided transrectal core biopsies of the prostate. J Urol 1989;142:71-5.
36. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995;45(1):2-11.
37. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-203.
38. Reitbergen JBW, Kruger AEB, Kranse R, Schroder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875-80.
39. Nava L, Montorsi F, Consonni P, Scattoni V, Guazonni G, Rigatti P. Results of a prospective randomized study comparing 6, 12, and 18 transrectal ultrasound-guided sextant biopsies in patients with elevated PSA normal DRE and normal prostate ultrasound. Urology 1997;226:59A.
40. Levine MA, Melamed J, Ittmann M, Lepor H. Two consecutive sets of transrectal ultrasound (TRUS) guided sextant biopsies of the prostate for the diagnosis of prostate cancer. J Urol 1997;244(157): 64A.
41. Brown M, True LD, Ellis WJ, Brawer MK. Does increased number of ultrasound-guided prostate needle biopsies enhance the yield of the chance of finding carcinoma. Urol J 1997;157(4): 144A.
42. Brawer MK, Chetner MP. Ultrasonography of the prostate and biopsy. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ, editors. Campbell's urology, Vol. 3. 7th ed. Philadelphia: Saunders, 1998.